Total Credits: 1 including 1 AOA Category 1-A Credit(s)
This lecture was presented at the 2023 IOA Virtual Spring Update by Jennifer Belsky, D.O. and Amber Brown, D.O.
Leukemia and lymphoma are among the top three most common malignancies diagnosed in children. Interpreting a CBC and evaluating for extramedullary disease, lymphadenopathy, and evidence of extramedullary hematopoiesis are important to determine the level of concern for a malignant process.
Learning Objectives:
Faculty Disclosure Declaration Statement
These presenters have no conflict of interest or disclosure to declare of any financial interest or other relationship with any commercial entities discussed in this educational presentation.
Accreditation Statement
This educational presentation was developed according to the planning, design, implementation and evaluation standards of the accreditation requirements for category 1 CME sponsors of the American Osteopathic Association (AOA). The Indiana Osteopathic Association (IOA) is accredited by the AOA to provide osteopathic continuing medical education for physicians.
Grievance Policy Statement
"It is the policy of the IOA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA. Complaints on Evaluation Forms also are taken into consideration when planning future CME programs and may lead to changes in the format or content." If you have any questions or concerns about this educational experience, you may call the IOA office at (317) 926-3009 or send an email message to info@inosteo.org. All questions or concerns will be addressed promptly.
| A Primary on Pediatric Acute Lymphoblastic Leukemia & Lymphoma | Available after Purchase | ||
Dr. Jennifer Belsky is an Assistant Professor of Pediatrics and Lead of the Pediatric Lymphoma Team at Riley Hospital for Children. She received her medical degree from Ohio University and completed Residency and Fellowship at Nationwide Children's Hospital and obtained a Master of Science from Wright State University. Her research is currently focused on supportive care clinical trials, with particular attention to chemotherapy induced side effects including neurotoxicity, constipation, and nausea/vomiting.
Dr. Brown, DO, MS is a Board-Certified Pediatrician, currently completing her Pediatric Hematology/Oncology Fellowship at Riley Hospital for Children in Indianapolis, IN. Dr. Brown completed medical school at Des Moines University in Des Moines, IA, and as part of her medical school training also completed an Osteopathic Manipulative Medicine (OMM) Fellowship. She completed her Pediatric Residency at Maine Medical Center in Portland, ME, where her research focused on the incorporation of OMM into the care of hospitalized pediatric patients with cancer or sickle cell disease. During her fellowship training, Dr. Brown plans to continue to incorporate OMM into the care of pediatric hematology and oncology patients and will be studying the effect of OMM on side effect mitigation in patients with cancer or sickle cell disease. Her additional clinical interests lie in high-risk malignancies, and she is interested in pursuing a career in oncocritical care.